1 to 10 of 24 literature results

• Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment.

  BACKGROUND/AIMS: Isolated liver angiomyolipomas (AMLs) occur in about 40% of TSC patients. Because of their slow growth, these tumors are often asympt…

  Authors: Ilaria Lenci, Mario Angelico, Giuseppe Tisone, Antonio Orlacchio, Giampiero Palmieri, Mariangela Pinci, Roberta Bombardieri, Paolo Curatolo

  Source: Journal of hepatology. 2008 Jun

  View Full Text

• A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

  BACKGROUND/AIMS: We performed a randomized trial on pegylated interferon alfa-2a (Peg-IFNalpha) monotherapy vs Peg-IFNalpha and ribavirin in non-cirrh…

  Authors: Mario Angelico, Alessandra Petrolati, Raffaella Lionetti, Ilaria Lenci, Patrizia Burra, Maria Francesca Donato, Manuela Merli, Mario Strazzabosco, Giuseppe Tisone

  Source: Journal of hepatology. 2007 Jun

  View Full Text

• Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.

  BACKGROUND/AIMS: HCV-related disease recurrence progresses rapidly after liver transplantation. We hypothesised that withdrawal of immunosuppression m…

  Authors: Giuseppe Tisone, Giuseppe Orlando, Andrea Cardillo, Giampiero Palmieri, Tommaso Maria Manzia, Leonardo Baiocchi, Raffaella Lionetti, Alessandro Anselmo, Luca Toti, Mario Angelico

  Source: Journal of hepatology. 2006 Apr

  View Full Text

• Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.

  BACKGROUND: Patients whose kidney grafts fail develop alloantibodies that react with many HLA molecules. We analyzed the epitope specificity of HLA cl…

  Authors: Antonina Piazza, Elvira Poggi, Giuseppina Ozzella, Laura Borrelli, Palmina I Monaco, Alessandra Scornajenghi, Giuseppe Tisone, Domenico Adorno

  Source: Transplantation. 2006 May 15

  View Full Text

• Operational tolerance in clinical liver transplantation: emerging developments.

  There is still little understanding of the immune events that occur in transplant patients as they develop a relationship with their graft alloantigen…

  Authors: Giuseppe Tisone, Giuseppe Orlando, Mario Angelico

  Source: Transplant immunology. 2007 Feb

  View Full Text

• Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience.

  OBJECTIVE: To report the results of a multicenter experience of split liver transplantation (SLT) with pediatric donors. SUMMARY BACKGROUND DATA: Ther…

  Authors: Matteo Cescon, Marco Spada, Michele Colledan, Giuliano Torre, Enzo Andorno, Umberto Valente, Giorgio Rossi, Paolo Reggiani, Umberto Cillo, Umberto Baccarani,…

  Source: Annals of surgery. 2006 Nov

  View Free Full Text

• Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report.

  Liver transplantation is a life-saving procedure for end-stage liver disease. In liver transplant recipients, morbid obesity influences post-operative…

  Authors: Paolo Gentileschi, Marco Venza, Domenico Benavoli, Francesca Lirosi, Ida Camperchioli, Marco D'Eletto, Alessandra Lazzaro, Vito M Stolfi, Alessandro Anselmo, Nicola Di Lorenzo,…

  Source: Obesity surgery. 2009 Oct

  View Full Text

• Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.

  BACKGROUND: In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal…

  Authors: Maurizio Salvadori, Maria Piera Scolari, Elisabetta Bertoni, Franco Citterio, Paolo Rigotti, Maria Cossu, Antonio Dal Canton, Giuseppe Tisone, Alberto Albertazzi, Francesco Pisani,…

  Source: Transplantation. 2009 Nov 27

  View Full Text

• Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.

  BACKGROUND: Cost of long-term prophylaxis with high-dose human hepatitis B immune globulin (HBIg) after liver transplantation is extremely high. The a…

  Authors: Daniele Di Paolo, Giuseppe Tisone, Paola Piccolo, Ilaria Lenci, Settimio Zazza, Mario Angelico

  Source: Transplantation. 2004 Apr 27

  View Full Text

• The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.

  BACKGROUND: We report the update of the Tor Vergata immunosuppression (IS) weaning protocol in stable hepatitis C virus (HCV) liver transplant (LT) re…

  Authors: Giuseppe Orlando, Tommaso Manzia, Leonardo Baiocchi, Alberto Sanchez-Fueyo, Mario Angelico, Giuseppe Tisone

  Source: Transplant immunology. 2008 Nov

  View Full Text